Immunotech Relocates to New Research & Development LaboratoryFacility Mar 1, 2013 09:15:24 (ET) PASADENA, CA, Mar 01, 2013 (MARKETWIRE via COMTEX) -- Immunotech Laboratories, Inc. (pinksheets:IMMB) today announced the company has relocated to a new Research & Development Lab facility in Monrovia, California. The new facility incorporates more laboratory use of the actual facility than the combined Administrative space at the previous Pasadena location. The new location also is geographically more conveniently located for the Immunotech team. In light of the recent announcements stating the HIV-AIDS and Hepatitis C clinical trials using the company's patented "ITV-1" patented technology treatment by the Immunotech BG sister company, more clinical research and results testing is necessary. The new facility accommodates the additional lab space. Utilizing a combination of the clinical tests and results being conducted in Bulgaria alongside the results analysis here in the USA at the new facility, Immunotech plans to submit all the results from the Bulgarian clinical trials for US Food & Drug Administration "FDA" approval on a pre IND meeting. Immunotech Laboratories plans to start working with IND Directions, LLC ( http://inddirections.com ) Immunotech's ultimate goal is to provide a worldwide FDA approved treatment for combating the HIV-AIDS virus with the intent of terminating the virus and restoring the immune system. The goal of this treatment is to achieve reduction of resistance of existing therapies on the market. The clinical trials in Bulgaria (Referred to as EU) are scheduled to begin in May 2013 and end in October 2013, which will give Immunotech, the rights to receive approval for applications of the "IPF" Treatment. In this respect, Immunotech Laboratories BG has had a series of conversations with Mr. Vladimir Stoichev, the Deputy General Director from Sopharma Bulgaria, and the parties have had talks for the possible signing of a contract between Immunotech Laboratories BG and Sopharma for joint production of IPF-ITV. Sopharma is a leading pharmaceutical company in the European Union. RELEVANT ARTICLES & LINKS FOR AIDS-HIV MEDICINES http://news.yahoo.com/gsk-wins-priority-statu...nance.html About Immunotech Laboratories Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and Aids. www.immunotechlab.com Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Immunotech Laboratories, Inc. from time to time in its periodic reports filed with the SEC. IPF is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Immunotech Laboratories believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Immunotech Laboratories to establish the efficacy of IPF in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of IPF in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, Immunotech Laboratories or any other person that the objectives and plans of Immunotech Laboratories will be achieved should not regard the forward-looking statements as a representation. Company Contact: Immunotech Laboratories, Inc. Email Contact Investor Relations: The Nabors Group 713-875-9200 E-mail: Email Contact
Immunotech Relocates to New Research Development
Top 10 Most Recent News Articles
Miracle Cocktails Unveils Global Expansion for 2026
Reimaging Spirits: Miracle's 12th Season is Here Holiday-themed cocktail pop-ups? That's Miracle Cocktails Inc. for you, making a splash since 2014 and showing no signs of slowing. This year, they're rolling out over 150 locations across the globe, sparking joy like a kid in a candy store. These aren't just bar crawls; they're full-blown holiday experiences that tickle...
Continue Reading
G20's Bold Move: Main Street Meets Wall Street
An Unexpected Invitation to the Elite Table You'd think a community bank from Oklahoma crashing a party of international finance heavyweights sounds odd, but that's exactly how the G20 threw down this year. Holding the reins, the U.S. took a swing at something different. Secretary of the Treasury Scott Bessent rolled out the red carpet for private-sector leaders,...
Continue Reading
Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone
Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...
Continue Reading
ePlus Wins Big: First Ambassador Partner for Everpure
ePlus Breaks Ground with Everpure There's a new chapter unfolding in the tech sector, and ePlus has carved its name on the marquee. Achieving the exclusive Ambassador Partner Status with Everpure, ePlus becomes the first in North America to hit this high note. In the crowded room of tech partnerships, this isn't just a pat on the back—it's a gold star that screams...
Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers
Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...
Continue Reading
Triskell Debuts in Gartner's 2026 Magic Quadrant
Triskell Software Makes Its Mark Kicking off September 2026 with a bang, Triskell Software finds itself on the illustrious 2026 Gartner Magic Quadrant for Adaptive Project Management and Reporting (APMR). This marks the first time the Madrid-based company nabs a spot here, and it's a significant feather in their cap. Just think, out of the 11 vendors invited to this...
Continue Reading
Early Education's Massive Impact: Key Skills for Success
Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...
Continue Reading
Hexaware Appoints New CEO Amid AI Growth Surge
Hexaware's Leadership Change: A Strategic Move Back in the day, leadership transitions in tech were like shooting craps—full of risk with no certainty. Today, Hexaware’s latest appointment isn’t just a roll of the dice. Appointing Vivek Jetley as CEO Designate is calculated, a strategic bid to ride the AI wave reshaping enterprise tech services. Meet the New Boss...
Continue Reading
Lear Corporation Talks Future at Morgan Stanley Conference
Why the Chatter at Laguna Conference Matters Alright folks, here's the scoop that the suits over at Lear are gearing up for: a fireside chat at the Morgan Stanley 14th Annual Laguna Conference. At first glance, you might shrug and say, "Big deal." But what's a conference worth if not to attract a bit of investor buzz, right? With Ray Scott, the President and CEO, and...
Continue ReadingSivers Semiconductors Expands Glasgow Facility Amid AI Boom
Big Moves in the Photonics World Sivers Semiconductors isn't messing around with its latest maneuver—a hefty USD 30 million investment plunked down to beef up their Indium Phosphide (InP) manufacturing plant in Glasgow, Scotland. It's the sort of bold move that tells you these folks have their eyes locked on the expanding AI infrastructure world like a hawk. The scale...
Continue ReadingTop 5 Most Recently Viewed Articles
Analysts Highlight Cigna's Strong Position in Health Insurance Market
Cigna Group Overview Cigna Group (NYSE: CI) has attracted attention from analysts for its strategic growth and resilience in the health insurance sector. The company is recognized for its strong positioning, especially in the commercial health insurance market, amid rising cost pressures and uncertainties affecting the broader industry. Market Analysis and Opportunities...
Continue Reading
AI Surge: The Rise of Niche Startups and Market Shifts
Sherwin Wu, OpenAI's engineering lead, has made waves with his hot take on how AI is set to reshape the startup arena. Forget the one-person billion-dollar companies—he's betting on a flood of smaller entities emerging instead. It’s a wild prediction but worth unpacking. Wu's core claim? The rise of AI tools is simplifying the path to creating new businesses. As these...
Continue Reading
Industry Veteran Todd Fulks Joins Succession Resource Group
Succession Resource Group Appoints Todd Fulks as General Counsel Succession Resource Group (SRG), a premier consulting firm focusing on wealth management business valuations, employment strategies, succession planning, and mergers & acquisitions (M&A), has announced the addition of Todd Fulks, JD, to its team as General Counsel. Fulks' Role and Contributions In this...
Continue Reading
Innovative Cooking Utensil Design Enhances Kitchen Efficiency
Revolutionizing Kitchen Tools with Innovative Designs Introducing a unique cooking utensil that changes the way we prepare our meals. An inventive mind from Gravenhurst, ON, Canada, has created a modified design for a cooking utensil, aptly named NO MESS WARE. This innovative invention focuses on the common struggle of keeping stirring spoons and forks securely placed on...
Continue Reading
Matador Technologies Boosts Bitcoin Strategy with Tranche Closing
Matador Technologies Finalizes Strategic Funding for Bitcoin Growth Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a forward-thinking technology company specializing in Bitcoin, is excited to share the successful closing of the final tranche of its non-brokered private placement. This funding round, part of a larger initiative...
Continue Reading